Repeated daily injections and osmotic pump infusion of isoproterenol cause similar increases in cardiac mass but have different effects on blood pressure
Authors:
- A Roger HohimerAHA Roger Hohimer
- Lowell E DavisLDLowell E Davis
- Daniel C HattonDHDaniel C Hatton
- 1 February 2005
- journal article
- Published by Canadian Science Publishing in Canadian Journal of Physiology and Pharmacology
- Vol. 83 (2) , 191-197
Abstract
We found in mice that repeated single daily subcutaneous (s.c.) isoproterenol (ISO) injections, like constant infusions using osmotic minipumps, caused increased biventricular mass or weight relative to body weight (VW/BW). We found that 5 (1/d) s.c. injections of 2, 10, or 20 µg/g body weight caused equivalent VW/BW increases as compared with 5-d infusions at 20 µg/(g·d)). While it is often presumed that ISO elicits hypertrophy by a direct effect on the myocytes, growth may also be secondary to systemic hemodynamic effects. The 2 modes of ISO administration had different effects on mean arterial blood pressure (MABP) and heart rate. Using telemetry we observed that single injections of ISO (0, 0.5, 2, and 10 µg/g) were associated with hypotension and tachycardia with a duration but not a magnitude that was dose dependent. MABP dropped rapidly to 60 mm Hg for more than 2 h at the highest dose. Constant s.c. infusion of ISO at 20 µg/(g·d) initially lowered MABP to about 70 mm Hg for 24 h. At 48 h MABP was normal, but rose 10 mm Hg higher than baseline by day 5. Thus, different routes of administration of ISO that cause comparable increases in VW/BW had different effects on MABP. Thus when evaluating mouse models of ISO-induced cardiac hypertrophy, both repeated daily injections or infusions can cause similar increases in VW/BW, but the daily doses that are required are not the same. Furthermore, these different routes of administration have different hemodynamic sequelae and could potentially evoke different cardiac phenotypes.Key words: C57BL6 mouse, hypotension, heart rate, cardiac hypertrophy, β-adrenergic.Keywords
This publication has 21 references indexed in Scilit:
- Regression of Isoproterenol-Induced Cardiac Hypertrophy by Na + /H + Exchanger InhibitionHypertension, 2003
- Perinatal Hypoxia Causes Ventricular Enlargement Associated with Increased Atrial Natriuretic Peptide (ANP) mRNA Levels in Newborn MiceHigh Altitude Medicine & Biology, 2003
- β-Adrenergic Activation Initiates Chamber Dilatation in Concentric HypertrophyHypertension, 2003
- Toxic cardiac effects of catecholamines: role of β-adrenoceptor downregulationEuropean Journal of Pharmacology, 2002
- Differential Effects of Intermittent and Continuous Administration of Parathyroid Hormone on Bone Histomorphometry and Gene ExpressionEndocrine, 2002
- Autonomous and Growth Factor–Induced Hypertrophy in Cultured Neonatal Mouse Cardiac MyocytesCirculation Research, 2000
- Expression of immediate early genes, GATA‐4, and Nkx‐2.5 in adrenergic‐induced cardiac hypertrophy and during regression in adult miceBritish Journal of Pharmacology, 1999
- Effects of Chronicβ-Adrenergic Receptor Stimulation in MiceJournal of Molecular and Cellular Cardiology, 1997
- Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis.Circulation Research, 1989
- Hypophysial Responses to Continuous and Intermittent Delivery of Hypothalamic Gonadotropin-Releasing HormoneScience, 1978